Abstract:Hypoxia is the major influence factor in physiological and pathological courses which are mainly mediated by hypoxia-inducible factors (HIFs) in response to low oxygen tensions within solid tumors. Under normoxia, HIF signaling pathway is inhibited due to HIF-α subunits degradation. However, in hypoxic conditions, HIF-α is activated and stabilized, and HIF target genes are successively activated, resulting in a series of tumour-specific activities. The activation of HIFs, including HIF-1α, HIF-2α and HIF-3α, subsequently induce downstream target genes which leads to series of responses, the resulting abnormal processes or metabolites in turn affect HIFs stability. Given its functions in tumors progression, HIFs have been regarded as therapeutic targets for improved treatment efficacy. Epigenetics refers to alterations in gene expression that are stable between cell divisions, and sometimes between generations, but do not involve changes in the underlying DNA sequence of the organism. And with the development of research, epigenetic regulation has been found to play an important role in the development of tumors, which providing accumulating basic or clinical evidences for tumor treatments. Here, given how little has been reported about the overall association between hypoxic tumors and epigenetics, we made a more systematic review from epigenetic perspective in hope of helping others better understand hypoxia or HIF pathway, and providing more established and potential therapeutic strategies in tumors to facilitate epigenetic studies of tumors.

The Role of HIF in Angiogenesis, Lymphangiogenesis, and Tumor Microenvironment in Urological Cancers

HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies

Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?

The Role of Hypoxia Inducible Factor-1 in Hepatocellular Carcinoma.

Role of hypoxia in the hallmarks of human cancer.

Tumor hypoxia: From basic knowledge to therapeutic implications

Small Molecules Targeting HIF-1α Pathway for Cancer Therapy in Recent Years

Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy.

A Molecular Perspective on HIF-1α and Angiogenic Stimulator Networks and Their Role in Solid Tumors: An Update

Hypoxia inducible factor-1α and oral tumor therapy

Hypoxia Signaling in Cancer: Implications for Therapeutic Interventions

HIF-1α pathway: role, regulation and intervention for cancer therapy

Epigenetic crosstalk between hypoxia and tumor driven by HIF regulation

The role of hypoxic microenvironment in the progress of tumor

HIF-1α: Its Role in Metastasis of Oesophageal Malignancy

Role of hypoxia-induced exosomes in tumor biology

Role of hypoxia in the tumor microenvironment and targeted therapy

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

Hypoxia-inducible factor-1 in tumour angiogenesis.

Hypoxia-mediated Activation of Hypoxia-Inducible Factor-1Α in Head and Neck Squamous Cell Carcinoma: A Review

Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes